FDA Investigator Jonathan W Chapman

Jonathan W Chapman has inspections in 4 countries as of 06 Oct 2023. Jonathan W Chapman has collaborated with a combinined 6041 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
66
Last Inspection Date:
06 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, China, France, Germany
Co-Investigator(s):
Adriana N Jimenez Lopez, Aimee Cunningham, PhD, Alberto A Viciedo, Alice S Tsao, Alison N Stieg, Amber G Chung, Amy Devlin, PhD, Amy N Chen, Anastasia G Lolas, Anastasia I Onuorah, Anastasia M Shields, Andrea Siegel, PhD, Andrew J Howard, Anjali Shukla, PhD, Annet R Rajan, Anthony A Charity, Anthony F Lorenzo, Anthony W Hite, Anthony W Lee, Arie C Menachem, Asamoah Asamoah, Atul J Agrawal, Austin B Appler, Barbara A Gullick, Barbara Janine Breithaupt, Bijoy Panicher, Bijoy Panicker, Bo Chi, PhD, Brandon L Mariner, Brenda W Uratani, PhD, Brian L Belz, Brian R Yaun, Brian R Yuan, Brooke K Higgins, Brooke K Secman, Brooke K Seeman, Bruce E Kummer, Bryan J Love, Burnell M Henry, Candice C Mandera, Candice J Cortes, Carole L Jones, Caroline Strasinger, Carrie L Doupnik, CDR Ileana Barreto Pettit, Chaltu N Wakijra, Charles E Idjagboro, Charles M Kerns, BLT DO, Chiang Syin, PhD, Christian D Lynch (CDL), Christina K Theodorou, Christopher T Middendorf, Chryste D Best, Clarice J Ahn, Cody D Rickman, Colleen F Hoyt, Collins M Mason, Concepcion Cruz, Jr, Constantin Y Philopoulos, Cynthia A Harris, MD, RN, Dandan Wang, PhD, David A Oluwo, David L Chon, David P Rice, Dennis Cantellops Paite, Dennis L Doupnik, Derek S Smith, PhD, Deyaa Shaheen, Diane L Raccasi, Diane T Bargo, Diane T O'bien, Diane T O'brien, Dianne H Milazzo, Dianne S Alexander, Donald C Obenhuber, PhD, Dongping Dai, PhD, Douglas A Campbell, Dr. Chunchang Fang, Dr. Dominick Roselle, Dr. Gang Wang, PhD, Dr. Ralph M Bernstein, PhD, Dr. Roslyn F Powers, Dr. Yubing Tang, Earl Echon, Edmund F Mrak, Jr, Edward P Potter, Edwin Melendez, Eileen A Liu, Emest F Bizjak, Emmanuel A Dimaano, Jr, Ephrem Hunde, PhD, Eric L Dong, BS, Erik T Nagaoka, Erik W Koester, Erika V Butler, Erin L Mcfiren, Erk W Koester, Esaw, Fabian Chaparro, Fabian Nchaparro Rodriguez, Frances Namuswe, PhD, Frank W Perrella, Gale L Glinecki, Gam S Zamil, Gayle S Lawson, George Pyramides, Gerald B Seaborn, Jr, Gifford Whitehurst, Jr, Guerlain Ulysse, Haoheng Yan, PhD, Heath R Harley, Hector J Colon Torres, Helen Verdel, Holly S Simms, Hongna Wang, Howard Anderson, PhD, Jacqueline Mdiaz Albertini, Jai P Singh, Jaison J Eapen, James M Mason, James M Simpson, James W Leonette, Jamie D Richardson, Jamie D Swann, Janet A Rajan, Jee Chung, PhD, Jeffrey D Meng, Jennifer Swisher, PhD, Jessica D Nanini, Jessica D Weber, Jessica Hankins, PhD, Jessica L Pressley, Jingbo Xiao, Joel D Hustedt, Joey C West, Jogy George, John D White, John Dan, John P Mistler, Johnna L Bleem, Johnson, Jonah S Ufferfilge, Jonah Ufferfilge, Jose E Melendez, DDC, Jose M Cayuela, Jose R Hernandez, Joseph W Matthews, Julie A Silberberg, Junho Pak, Justin A Boyd, Kalavati Suvarna, PhD, Kara D Dobbin, Karen A Briggs, Katelyn Astaub Zamperini, Katherine Szestypalow, Kathleen M Jordan, Kathy Lee, Kelly L Anderson, Kenneth Gordon, Kenneth M Gordon, Kenneth Nieves, Kevin A Gonzalez, Kham Phommachanh, Ko U Min, Kristina L Conroy, Kshitij A Patkar, La Tasha M Gunter, Lakisha M Williams, Lara M Snyder, Latorie S Jones, Lauren N Barber, Laurissa S Flowers, Lawrence Harmon, Jr, Lawrence J Stringer, LCDR Anastasia Mpiliafas Brown, LCDR Cornelius Brown, III, LCDR Debra Emerson, Li Lu, PhD, Liatte Kreuger, PharmD, Linda J Eason, Lindsey M Schwierjohann, Lori S Lawless, LT Richard A Lyght, Luella J Rossi, Luis A Dasta, Madushini Dharmasena, PhD, Malgorzata G Norton, Marc S Neubauer, Marcellinus D Dordunoo, Marcus A Ray, Margaret H Waters, Margaret M Doherty, Maria Gutierrez Lugo, PhD, Maria Joselopez Barragan, PhD, Marie F Morin, Marion Michaelis, Mary E Farbman, PhD, Massoud Motamed, Matthew B Casale, Matthew M Henciak, Matthew R Mcnew, Mekonnen Lemma Dechassa, PhD, Melissa J Garcia, Melissa T Roy, Merideth K Rose, Michael A Taylor, Michael J Vardon, Michael Shanks, MS, Michelle Marsh, Mihaly S Ligmond, Mindy M Chou, Miriam D Stuckey, Mohamad A Chahine, Monique Rac Lester, Mra Davism, Nadeem I Chaudhry, Nancy M Espinal, Nash, Nawab A Siddiqui, Nebil A Oumer, Nerizza B Guerin, Nicholas A Violand, Nicole K Trudel, Nina D Patel, Omotunde O Osunsanmi, Parul M Patel, Parul Patel Sullivan, Patricia A Morrow, Patricia Fhughes Troost, Paul L Bellamy, Paula J Bretz, Pelekakis, Peter E Baker, Philip W Beck, Prabhu P Raju, Pratik S Upadhyay, DDC, Qin Xu, Quyen T Tran, Rabin N Ghoshal, Rachael O Oyewole, Rachael Oyewole, Rachel C Harrington, Ramesh Potla, PhD, Reba A Gates, Rebecca E Dombrowski, Rebecca Rodriguez, Regina Gibson Melton, Renisha M Shaw, Richard Ledwidge (nmi), PhD, Richard W Thornton, Rina Bhikha, Robert H Wittorf, Robert J Maffei, Robert J Martin, Robin Levis, PhD, Roger F Zabinski, Rose M Ashley, Ruark Lanham, Saleem A Akhtar, Sam Pepe, Samina S Khan, Sangeeta M Khurana, PhD, Santos E Camara, Scott R Nichols, PhD, Scott T Ballard, Sean R Marcsisin, Sena G Dissmeyer, Shadia Zaman, PhD, Sharon K Thoma, PharmD, Shelby W Brown, Sherry L Secrist, BLT DO, Shirshendu K Deb, PhD, Shusheen A Alexander, Simone E Pitts, Slatten, Sneha Patel, Sneha S Patel, Stacie A Woods, State Agency, Stephanie A Slater, MS, Stephanie L Shapley, Steven E Bowen, PhD, Steven J Thurber, Steven Kozlowski, MD, Steven P Donald, Susan J Essenmacher, Susan M Jackson, Suzanne M Healy, Suzanne M Muchene, Swati Verma, Tajah L Blackburn, Tamara N Champion, Tamika White, Tamil Arasu, PhD, Tania E Vizcaino, Temar Q Williams, Teresa I Navas, Thai D Truong, Theresa Kirkham (NMI), Thomas, Thomas E Friel, Thomas J Arista, Thomas R Withers, Thuy T Nguyen, LCDR, Thuy Y Nguyen, Tiki J Dixon, Timothy M Albright, Tonia F Bernard, Torrance J Slayton, Toyin B Oladimeji, Valeria A Moore, Vesna V Stanoyevitch, Vincent Thomas, Vipulchandr N Dholakia, Viviana Matta, Vivin George, Walter Fava, Walter L Fava, Wanda Y Honeyblue, Wayne L Jefferson, William A Warnick, William D Bassett, Jr, William D Murray, William H Linkroum, William J Leonard, William L Bargo, Xiaoshi Wang, Xu Michael Di, PhD, Yasamin Ameri, Yvette I Johnson, Yvins Dezan, Zedong Dong, Zhao Wang, PhD, Zhihao Qiu (Peter), PhD, Zhong Li, PhD, Zhongren Wu

Jonathan W Chapman's Documents

Publish Date Document Type Title
May, 2015 FDA 483 Pharmaceutics International, Inc. - Form 483, 2015-05-29
March, 2019 FDA 483 Yino, Inc. - Form 483, 2019-03-22
November, 2014 EIR Microbiological Consultants, Inc. - EIR, 2014-11-07
March, 2019 FDA 483 Taizhou Kangping Medical Science And Technology Co., Ltd. - Form 483, 2019-03-07
April, 2014 EIR Cangene BioPharma, LLC - EIR, 2014-04-09
September, 2017 EIR Afton Scientific, LLC - EIR, 2017-09-15
April, 2014 FDA 483 Cangene BioPharma, LLC - Form 483, 2014-04-09
April, 2015 FDA 483 Mylan Pharmaceuticals Inc. - Form 483, 2015-04-24
August, 2019 FDA 483 Shanghai Desano Bio-Pharmaceutical Co., Ltd. - Form 483, 2019-08-02
April, 2016 EIR Human Genome Sciences, Inc. - EIR, 2016-04-11
November, 2018 FDA 483 Xiamen LP Pharmaceutical Co., Ltd. - Form 483, 2018-11-16
March, 2014 EIR Mylan Pharmaceuticals Inc. - EIR, 2014-03-21
September, 2016 FDA 483 Johns Hopkins University, The - Form 483, 2016-09-02
April, 2021 FDA 483 WuXi Biologics Co., Ltd. - Form 483, 2021-04-02
February, 2017 FDA 483 Response Supernus Pharmaceuticals Inc - Form 483R, 2017-02-03
March, 2016 FDA 483 Pharmaceutics International, Inc. - Form 483, 2016-03-18
September, 2017 FDA 483 Afton Scientific, LLC - Form 483, 2017-09-15
January, 2019 FDA 483 Aurisco Pharmaceutical Co., Ltd. - Form 483, 2019-01-25
May, 2016 FDA 483 Bell-More Labs Inc - Form 483, 2016-05-26
April, 2014 FDA 483 Afton Scientific, LLC - Form 483, 2014-04-25
March, 2016 EIR Pharmaceutics International, Inc. - EIR, 2016-03-18
February, 2017 EIR Supernus Pharmaceuticals Inc - EIR, 2017-02-03
April, 2018 FDA 483 Hangzhou Zhongbo Industrial Co., Ltd. - Form 483, 2018-04-27
February, 2017 FDA 483 Supernus Pharmaceuticals Inc - Form 483, 2017-02-03
April, 2015 EIR Mylan Pharmaceuticals Inc. - EIR, 2015-04-24
October, 2017 FDA 483 Pharmaceutics International, Inc. - Form 483, 2017-10-27
March, 2014 FDA 483 Mylan Pharmaceuticals Inc. - Form 483, 2014-03-21
August, 2018 FDA 483 Response AstraZeneca Pharmaceuticals LP - Form 483R, 2018-08-29
August, 2014 FDA 483 Konsyl Pharmaceuticals, Inc. - Form 483, 2014-08-01
April, 2021 EIR WuXi Biologics Co., Ltd. - EIR, 2021-04-02
November, 2014 FDA 483 Microbiological Consultants, Inc. - Form 483, 2014-11-07
May, 2019 FDA 483 Zhejiang Huahai Pharmaceutical Co., Ltd. - Form 483, 2019-05-31
April, 2017 FDA 483 Barr Laboratories Inc. - Form 483, 2017-04-14
February, 2016 FDA 483 Stressa Incorporated - Form 483, 2016-02-03
October, 2019 FDA 483 Viwit Pharmaceutical Co., Ltd. - Form 483, 2019-10-18
July, 2019 EIR WuXi AppTec (Shanghai) Co., Ltd. - EIR, 2019-07-18
July, 2018 FDA 483 Izeen Pharma Inc - Form 483, 2018-07-03
April, 2019 FDA 483 Hainan Shuangcheng Pharmaceuticals Co., Ltd. - Form 483, 2019-04-24
June, 2019 FDA 483 Zhejiang Huahai Pharmaceutical Co., Ltd. - Form 483, 2019-06-28
August, 2018 FDA 483 AstraZeneca Pharmaceuticals LP - Form 483, 2018-08-17
October, 2020 FDA 483 Shandong Anhong Pharmaceutical Co., Ltd. - Form 483, 2020-10-30
March, 2015 FDA 483 C.B. Fleet Company, Inc. - Form 483, 2015-03-12

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more